February 17, 2015

McKesson on Tuesday announced that Bansi Nagji has been appointed EVP corporate strategy and business development.

February 6, 2015

McKesson on Thursday reported that revenues for the third quarter ended Dec. 31, 2014 totaled $47 billion, up 37% compared to $34.3 billion a year ago.

December 2, 2014

McKesson on Tuesday announced that the Stuttgart Higher Regional Court approved the registration of the domination and profit and loss transfer agreement between Celesio and McKesson Deutschland.

October 29, 2014

McKesson reported that revenues for the second quarter ended Sept. 30 were $44.8 billion, up 36% compared with the year-ago period.  

 

July 31, 2014

McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%. 

May 13, 2014

McKesson reported that revenues for the fourth quarter ended March 31 were $38.1 billion, up 25%.

April 7, 2014

McKesson on Monday announced that the results of the initial acceptance period of the voluntary public takeover offer for the remaining shares of Celesio AG have been published.

February 28, 2014

McKesson on Friday announced that the wholesaler has launched a voluntary public takeover offer for the remaining outstanding shares of Celesio through its indirect wholly-owned subsidiary, Dragonfly.

February 6, 2014

McKesson confirmed that it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio shares.

January 31, 2014

Days following the acquisition of a majority stake in Celesio, McKesson Corp. reported that revenues for the third quarter ended Dec. 31 totaled $34.3 billion, up 10% compared with a year ago.

January 31, 2014

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

Nothing good is ever easy. "While the path to securing this acquisition was certainly not what we had originally expected, it would seem that the interested parties to this transaction continued to see the compelling strategic benefit of McKesson and Celesio uniting to form a global leader in health care services," John Hammergren, McKesson chairman, CEO and president, said of the deal. "I never lost sight of the value this transaction will bring to our customers, our supply chain partners, the employees of both organizations and our shareholders."

January 24, 2014

McKesson announced that it has reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares for 23.50 euros per share (US $32.24 per share).

January 14, 2014

McKesson may take another bite of the Celesio apple, suggested Sterne Agee analyst Greg Bolan in a note published Monday.

January 13, 2014

McKesson on Monday announced that it was unsuccessful in reaching the 75% completion condition in its offer for the outstanding shares and convertible bonds of Celesio.

January 9, 2014

A deal announced last month between CVS Caremark and Cardinal Health created a joint venture that the companies said would be the largest generic drug sourcing entity in the United States.

January 9, 2014

Rather than take vacation for Christmas and New Year’s, the editors of DSN worked to compile a list of the top 10 trends that will shake up the business in 2014.

January 9, 2014

McKesson Corp. has reached an agreement with Franz Haniel & Cie. GmbH, currently representing a 50.01% stake in Celesio, to sweeten the purchase price for its shareholding in Celesio to EUR 23.50 per share.

January 8, 2014

McKesson is preparing to offer concessions to hedge fund Elliott to save its planned acquisition of Celesio, Reuters reported Wednesday morning, citing people familiar with the deal.

December 10, 2013

The hedge fund Elliott Management will attempt to block McKesson's offer to acquire the German pharmaceutical wholesaler Celesio because it “substantially undervalues” the company, according to a report in the New York Times published Tuesday.

December 5, 2013

McKesson announced that the company has launched the voluntary public takeover offer for the outstanding shares of Celesio through its indirect, wholly-owned subsidiary Dragonfly in connection with the announcement on Oct. 24 of McKesson’s agreement to acquire Celesio.

October 25, 2013

With is proposed acquisition of German wholesaler Celesio, McKesson creates a global distribution enterprise on the scale of Walgreens, Alliance Boots and AmerisourceBergen before them. In addition to wholesaling, Celesio operates about 2,200 pharmacies across six countries and is the No. 2 operator in the United Kingdom.

Retail pharmacy and drug sourcing both are more and more becoming a global business. Just last week, the head of the second-biggest drug chain in Brazil announced he would be open to a buyout. So expect more of these headlines in the months to come.

October 24, 2013

McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.

October 23, 2013

McKesson appears ready to pull the trigger on an offer for German drug distributor Celesio, The Wall Street Journal reported Wednesday.